Telemedicine has rapidly transformed healthcare delivery during the COVID-19 pandemic, but innovative reimbursement models and updated privacy regulations are needed to ensure widespread implementation of high-quality digital care.
It is clear that clinical trials now exist in a different world from what researchers, IRBs, and sponsors experienced in 2019. The key challenges are how to restart clinical trials, how to return to in-person visits, and how to manage the growing number of studies related to COVID-19.
Remember that the pandemic response may create unique Health Insurance Portability and Accountability Act compliance risks. Time, staffing, and focus are at a premium, but staying cognizant of patients’ privacy remains important.
The combination of a highly infectious virus and a frail resident population in a closed environment — where infection control has been historically difficult to implement — has resulted in devastating outbreaks of COVID-19 in U.S. nursing homes.
Family planning clinics and other reproductive health providers have discovered creative ways to continue to provide contraception services to women during the COVID-19 pandemic. Telehealth is one of the most important methods, although each facility has its own way of using remote services.